Sergio Traversa insider trades

Open-market stock purchases and sales by Sergio Traversa, Chief Executive Officer at Relmada Therapeutics, Inc, from SEC Form 4 filings since Aug 8, 2013.

Track record: 100% of 19 scored buys are up 5% or more since purchase, averaging +87%.

Recent trades

DateStockTradeValue
Dec 15, 2025RLMD Relmada Therapeutics, IncBought$113K
Dec 12, 2025RLMD Relmada Therapeutics, IncBought (not open market)—
Nov 5, 2025RLMD Relmada Therapeutics, IncBought$600K

Companies traded

  • RLMD Relmada Therapeutics, Inc: 25 buys, 24 sales, last Dec 15, 2025
  • ATNM Actinium Pharmaceuticals, Inc: 2 buys, last Mar 14, 2017

Get free alerts when Sergio Traversa files a new trade →